PGR and breast cancer: 3.3. Expression of MiR-190a, MiR-190b, MiR-27a, MiR-193b, MiR-324, MiR-423, MiR-200b, and MiR-21 in Relation to Clinicopathologic Features of ER- and/or PR-Positive BC